Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts

Marc N. Elliott, Bruce E. Landon, Alan M. Zaslavsky, Carol A. Edwards, Nathan Orr, Megan K. Beckett, Joshua Mallett, Paul Cleary

ResearchPosted on rand.org Mar 14, 2016Published in: Health Affairs, v. 35, no. 3, Mar. 2016, p. 456-463

Since 2006, Medicare beneficiaries have been able to obtain prescription drug coverage through standalone prescription drug plans or their Medicare Advantage (MA) health plan, options exercised in 2015 by 72 percent of beneficiaries. Using data from community-dwelling Medicare beneficiaries older than age sixty-four in 700 plans surveyed from 2007 to 2014, we compared beneficiaries' assessments of Medicare prescription drug coverage when provided by standalone plans or integrated into an MA plan. Beneficiaries in standalone plans consistently reported less positive experiences with prescription drug plans (ease of getting medications, getting coverage information, and getting cost information) than their MA counterparts. Because MA plans are responsible for overall health care costs, they might have more integrated systems and greater incentives than standalone prescription drug plans to provide enrollees medications and information effectively, including, since 2010, quality bonus payments to these MA plans under provisions of the Affordable Care Act.

Key Takeaways

  • Nationally, Medicare Advantage beneficiaries with integrated prescription drug plans (MA-PD enrollees) had better prescription drug experiences than Medicare beneficiaries enrolled in standalone prescription drug plans.
  • MA-PD enrollees reported greater ease of getting medications, as well as information about cost and coverage, than did standalone prescription drug plan enrollees.
  • Both groups of beneficiaries rated their prescription drug plans less positively than other aspects of health care, although in general ratings were quite positive.
  • Ratings in both populations increased over time, from 2007 to 2014, including reports on the ease of obtaining needed drugs.

Topics

Document Details

  • Availability: Non-RAND
  • Year: 2016
  • Pages: 8
  • Document Number: EP-66376

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.